Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectives

被引:20
作者
Rocca, Maria A. [1 ,2 ]
Preziosa, Paolo [1 ]
Filippi, Massimo [1 ,2 ]
机构
[1] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Div Neurosci, Neuroimaging Res Unit,Inst Expt Neurol, Milan, Italy
[2] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Div Neurosci, Dept Neurol,Inst Expt Neurol, Milan, Italy
关键词
Disease modifying treatments; magnetic resonance imaging; multiple sclerosis; rehabilitation; treatment monitoring; MAGNETIZATION-TRANSFER RATIO; PLACEBO-CONTROLLED TRIAL; SUBCUTANEOUS INTERFERON BETA-1A; BRAIN VOLUME LOSS; STEM-CELL TRANSPLANTATION; WHITE-MATTER PATHOLOGY; SPINAL-CORD VOLUME; HIGH-YIELD PROCESS; GLATIRAMER ACETATE; DOUBLE-BLIND;
D O I
10.1080/14737175.2019.1555038
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Advances in magnetic resonance imaging (MRI) technology and analyses are improving our understanding of the pathophysiology of multiple sclerosis (MS). Due to their ability to grade the presence of irreversible tissue loss, microstructural tissue abnormalities, metabolic changes and functional plasticity, the application of these techniques is also expanding our knowledge on the efficacy and mechanisms of action of different pharmacological and rehabilitative treatments. Areas covered: This review discusses recent findings derived from the application of advanced MRI techniques to evaluate the structural and functional substrates underlying the effects of pharmacologic and rehabilitative treatments in patients with MS. Current applications as outcome in clinical trials and observational studies, their interpretation and possible pitfalls in their use are discussed. Finally, how these techniques could evolve in the future to improve monitoring of disease progression and treatment response is examined. Expert commentary: The number of treatments currently available for MS is increasing. The application of advanced MRI techniques is providing reliable and specific measures to better understand the targets of different treatments, including neuroprotection, tissue repair, and brain plasticity. This is a fundamental progress to move toward personalized medicine and individual treatment selection.
引用
收藏
页码:835 / 866
页数:32
相关论文
共 224 条
[91]   Cognitive rehabilitation of working memory in juvenile multiple sclerosis-effects on cognitive functioning, functional MRI and network related connectivity [J].
Hubacher, Martina ;
DeLuca, John ;
Weber, Peter ;
Steinlin, Maja ;
Kappos, Ludwig ;
Opwis, Klaus ;
Penner, Iris-Katharina .
RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 2015, 33 (05) :713-725
[92]   A pilot study of changes in functional brain activity during a working memory task after mSMT treatment: The MEMREHAB trial [J].
Huiskamp, M. ;
Dobryakova, E. ;
Wylie, G. D. ;
DeLuca, J. ;
Chiaravalloti, N. D. .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 7 :76-82
[93]   rTMS affects working memory performance, brain activation and functional connectivity in patients with multiple sclerosis [J].
Hulst, H. E. ;
Goldschmidt, T. ;
Nitsche, M. A. ;
de Wit, S. J. ;
van den Heuvel, O. A. ;
Barkhof, F. ;
Paulus, W. ;
van der Werf, Y. D. ;
Geurts, J. J. G. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (05) :386-394
[94]   The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue [J].
Huolman, S. ;
Hamalainen, P. ;
Vorobyev, V. ;
Ruutiainen, J. ;
Parkkola, R. ;
Laine, T. ;
Hamalainen, H. .
MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (11) :1351-1361
[95]   Fractional anisotropy and mean diffusivity in the corpus callosum of patients with multiple sclerosis: the effect of physiotherapy [J].
Ibrahim, Ibrahim ;
Tintera, Jaroslav ;
Skoch, Antonin ;
Jiru, Filip ;
Hlustik, Petr ;
Martinkova, Patricia ;
Zvara, Karel ;
Rasova, Kamila .
NEURORADIOLOGY, 2011, 53 (11) :917-926
[96]  
Inglese M, 2004, J NEUROL NEUROSUR PS, V75, P643
[97]   The effect of interferon β-1b on quantities derived from MT MRI in secondary progressive MS [J].
Inglese, M ;
van Waesberghe, JHTM ;
Rovaris, M ;
Beckmann, K ;
Barkhof, F ;
Hahn, D ;
Kappos, L ;
Miller, DH ;
Polman, C ;
Pozzilli, C ;
Thompson, AJ ;
Yousry, TA ;
Wagner, K ;
Comi, G ;
Filippi, M .
NEUROLOGY, 2003, 60 (05) :853-860
[98]   The therapeutic use of non-invasive brain stimulation in multiple sclerosis - a review [J].
Iodice, Rosa ;
Manganelli, Fiore ;
Dubbioso, Raffaele .
RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 2017, 35 (05) :497-509
[99]   A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis [J].
Kaiser, Claudia C. ;
Shukla, Dinesh K. ;
Stebbins, Glenn T. ;
Skias, Demetrios D. ;
Jeffery, Douglas R. ;
Stefoski, Dusan ;
Katsamakis, George ;
Feinstein, Douglas L. .
JOURNAL OF NEUROIMMUNOLOGY, 2009, 211 (1-2) :124-130
[100]   The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study [J].
Kalkers, NF ;
Barkhof, F ;
Bergers, E ;
van Schijndel, R ;
Polman, C .
MULTIPLE SCLEROSIS, 2002, 8 (06) :532-533